A method for diagnosing Parkinson's and Alzheimer's disease without invasive techniques or complicated wet-laboratory equipment. The method utilizes the rapid detection of both the CD38 protein and alpha-synuclein protein at a specific concentration that reflects the pathological state of Parkinson's disease, and CD38 protein and the tau protein which are found in significantly elevated concentrations in blood plasma and serum in the disease states. The blood plasma or serum can be collected and utilized as the test material for the pre- and post-symptom Parkinson's disease and Alzheimer's disease.
RAPID MULTIPLEX DIAGNOSTIC FOR PARKINSON'S DISEASE AND ALZHEIMER'S DISEASE